Congress criticises drugs industry for misleading advertisingBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7377.1379/a (Published 14 December 2002) Cite this as: BMJ 2002;325:1379
- Scott Gottlieb
- New York
Some companies have disseminated misleading advertisements for prescription drugs, even after being cited for violations, a report issued by the US Congress says.
Congressional investigators, from the independent General Accounting Office, also said that drug advertising seemed to produce a major increase in the use of prescription drugs. The study estimated that at least 8.5 million Americans each year request and receive …